Abstract
Elk-1, a c-Fos protooncogene regulator, which belongs to the ETS-domain family of transcriptional factors, plays an important role in the induction of immediate early gene expression in response to a variety of extracellular signals. In this study, we demonstrate for the first time the in vitro and in vivo interaction of Elk-1 with BRCA1 splice variants BRCA1a and BRCA1b using GST-pull down assays, co-imunoprecipitations/Western blot analysis of cell extracts from breast cancer cells and mammalian two-hybrid assays. We have localized the BRCA1 interaction domain of Elk-1 protein to the conserved ETS domain, a motif involved in DNA binding and protein–protein interactions. We also observed binding of BRCA1 proteins to other ETS-domain transcription factors SAP1, ETS-1, ERG-2 and Fli-1 but not to Elk-1 splice variant ΔElk-1 and c-Fos protooncogene. Both BRCA1a and BRCA1b splice variants function as growth suppressors of human breast cancer cells. Interestingly, our studies reveal that although both Elk-1 and SAP-1 are highly homologous members of a subfamily of ETS domain proteins called ternary complex factors, it is only Elk-1 but not SAP-1 that can augment the growth suppressive function of BRCA1a/1b proteins in breast cancer cells. Thus Elk-1 could be a potential downstream target of BRCA1 in its growth control pathway. Furthermore, we have observed inhibition of c-Fos promoter activity in BRCA1a transfected stable breast cancer cells and over expression of BRCA1a/1b attenuates MEK-induced SRE activation in vivo. These results demonstrate for the first time a link between the growth suppressive function of BRCA1a/1b proteins and signal transduction pathway involving Elk-1 protein. All these results taken together suggest that one of the mechanisms by which BRCA1a/1b proteins function as growth/tumor suppressors is through inhibition of the expression of Elk-1 target genes like c-Fos.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Abate C, Luk D, Curran T . 1991 Mol. Cell. Biol. 11: 3624–3632
Anderson SF, Schlegel BP, Nakajima T, Wolpin ES, Parvin JD . 1998 Nat. Genet. 19: 254–256
Bhattacharya G, Lee L, Reddy ES, Rao VN . 1993 Oncogene 8: 3459–3464
Bork P, Hofmann K, Bucher P, Neuwald AF, Altschul SF, Koonin EV . 1997 FASEB J. 11: 68–76
Brugarolas J, Jacks T . 1997 Nat. Med. 3: 721–722
Callebaut I, Mornon JP . 1997 FEBS Lett. 400: 25–30
Chai YL, Cui J, Shao N, Shyam E, Reddy P, Rao VN . 1999 Oncogene 18: 263–268
Chapman MS, Verma IM . 1996 Nature 382: 678–679
Chen J, Silver DP, Walpita D, Cantor SB, Gazdar AF, Tomlinson G, Couch FJ, Weber BL, Ashley T, Livingston DM, Scully R . 1998 Mol. Cell. 2: 317–328
Couch FJ, Weber BL . 1996 Hum. Mutat. 8: 8–18
Cui JQ, Shao N, Chai Y, Wang H, Reddy ES, Rao VN . 1998a Oncol. Rep. 5: 591–595
Cui JQ, Wang H, Reddy ES, Rao VN . 1998b Oncol. Rep. 5: 585–589
Dalton S, Treisman R . 1992 Cell 68: 597–612
Drewett V, Muller S, Goodall J, Shaw PE . 2000 J. Biol. Chem. 275: 1757–1762
Easton DF, Ford D, Bishop DT . 1995 Am. J. Hum. Genet. 56: 265–271
Fan S, Wang JA, Yuan RQ, Ma YX, Meng Q, Erdos MR, Brody LC, Goldberg ID, Rosen EM . 1998 Oncogene 16: 3069–3082
Ford D, Easton DF, Peto J . 1995 Am. J. Hum. Genet. 57: 1457–1462
Giovane A, Pintzas A, Maira SM, Sobieszczuk P, Wasylyk B . 1994 Genes. Dev. 8: 1502–1513
Gupta S, Barrett T, Whitmarsh AJ, Cavanagh J, Sluss HK, Derijard B, Davis RJ . 1996 EMBO J. 15: 2760–2770
Hill CS, Marais R, John S, Wynne J, Dalton S, Treisman R . 1993 Cell 73: 395–406
Hipskind RA, Rao VN, Mueller CG, Reddy ES, Nordheim A . 1991 Nature 354: 531–534
Holt JT, Thompson ME, Szabo C, Robinson-Benion C, Arteaga CL, King MC, Jensen RA . 1996 Nat. Genet. 12: 298–302
Humphrey JS, Salim A, Erdos MR, Collins FS, Brody LC, Klausner RD . 1997 Proc. Natl. Acad. Sci. USA 94: 5820–5825
Jensen DE, Proctor M, Marquis ST, Gardner HP, Ha SI, Chodosh LA, Ishov AM, Tommerup N, Vissing H, Sekido Y, Minna J, Borodovsky A, Schultz DC, Wilkinson KD, Maul GG, Barlev N, Berger SL, Prendergast GC, Rauscher 3rd FJ . 1998 Oncogene 16: 1097–1112
Katsama A, Sourvinos G, Zachos G, Spandidos DA . 2000 Cancer Lett. 150: 165–170
Koonin EV, Altschul SF, Bork P . 1996 Nat. Genet. 13: 266–268
Lane TF, Deng C, Elson A, Lyu MS, Kozak CA, Leder P . 1995 Genes. Dev. 9: 2712–2722
Lopez M, Oettgen P, Akbarali Y, Dendorfer U, Libermann TA . 1994 Mol. Cell. Biol. 14: 3292–3309
Lu M, Conzen SD, Cole CN, Arrick BA . 1996 Cancer Res. 56: 4578–4581
Marais R, Wynne J, Treisman R . 1993 Cell 73: 381–393
Marquis ST, Rajan JV, Wynshaw-Boris A, Xu J, Yin GY, Abel KJ, Weber BL, Chodosh LA . 1995 Nat. Genet. 11: 17–26
Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonin P, Narod S, Bristow PK, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett T . 1994 Science 266: 66–71
Monteiro AN, August A, Hanafusa H . 1996 Proc. Natl. Acad. Sci. USA 93: 13595–13599
Nozaki M, Onishi Y, Kanno N, Ono Y, Fujimura Y . 1996 DNA. Cell. Biol. 15: 855–862
Ozcelik H, To MD, Couture J, Bull SB, Andrulis IL . 1998 Int. J. Cancer 77: 1–6
Price MA, Rogers AE, Treisman R . 1995 EMBO J. 14: 2589–2601
Rao VN, Huebner K, Isobe M, ar-Rushdi A, Croce CM, Reddy ES . 1989 Science 244: 66–70
Rao VN, Ohno T, Prasad DD, Bhattacharya G, Reddy ES . 1993 Oncogene 8: 2167–2173
Rao VN, Papas TS, Reddy ES . 1987 Science 237: 635–639
Rao VN, Reddy ES . 1992 Oncogene 7: 2335–2340
Rao VN, Reddy ES . 1993 Cancer Res. 53: 215–220
Rao VN, Shao N, Ahmad M, Reddy ES . 1996 Oncogene 12: 523–528
Reddy ES, Rao VN . 1990 Cancer Res. 50: 5013–5016
Scully R, Anderson SF, Chao DM, Wei W, Ye L, Young RA, Livingston DM, Parvin JD . 1997a Proc. Natl. Acad. Sci. USA 94: 5605–5610
Scully R, Chen J, Plug A, Xiao Y, Weaver D, Feunteun J, Ashley T, Livingston DM . 1997b Cell 88: 265–275
Shao N, Chai Y, Cui JQ, Wang N, Aysola K, Reddy ES, Rao VN . 1998 Oncogene 17: 527–532
Shao N, Chai YL, Shyam E, Reddy P, Rao VN . 1996 Oncogene 13: 1–7
Shore P, Sharrocks AD . 1995 Nucleic Acids Res. 23: 4698–4706
Somasundaram K, Zhang H, Zeng YX, Houvras Y, Peng Y, Wu GS, Licht JD, Weber BL, El-Deiry WS . 1997 Nature 389: 187–190
Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M, Timmerman MM, Brody LC, Tucker MA . 1997 N. Engl. J. Med. 336: 1401–1408
Thompson ME, Jensen RA, Obermiller PS, Page DL, Holt JT . 1995 Nat. Genet. 9: 444–450
Wang H, Shao N, Ding QM, Cui J, Reddy ES, Rao VN . 1997 Oncogene 15: 143–157
Wang Q, Zhang H, Kajino K, Greene MI . 1998 Oncogene 17: 1939–1948
Wasylyk B, Hagman J, Gutierrez-Hartmann A . 1998 Trends Biochem. Sci. 23: 213–216
Whitmarsh AJ, Shore P, Sharrocks AD, Davis RJ . 1995 Science 269: 403–407
Wilson CA, Payton MN, Elliott GS, Buaas FW, Cajulis EE, Grosshans D, Ramos L, Reese DM, Slamon DJ, Calzone FJ . 1997 Oncogene 14: 1–16
Wu LC, Wang ZW, Tsan JT, Spillman MA, Phung A, Xu XL, Yang MC, Hwang LY, Bowcock AM, Baer R . 1996 Nat. Genet. 14: 430–440
Yates PR, Atherton GT, Deed RW, Norton JD, Sharrocks AD . 1999 EMBO J. 18: 968–976
Yu X, Wu LC, Bowcock AM, Aronheim A, Baer R . 1998 J. Biol. Chem. 273: 25388–25392
Zhang H, Somasundaram K, Peng Y, Tian H, Bi D, Weber BL, El-Deiry WS . 1998 Oncogene 16: 1713–1721
Acknowledgements
We thank T Kouzarides for GAL4 reporter and expression plasmids, T Curran for the c-Fos plasmid, R Treisman for SAP1a plasmid, J Gioanne for the CAL-51 cell line, RJ Davis for pSRE×2 luciferase reporter plasmid and NG Ahn for pCMV-MEK-DN plasmid. We thank L Boyer for secretarial assistance. We also thank the other members of Rao and Reddy laboratories for their help. This work was supported by NIH grant RO1CA57322 and a clinical research infrastructure award from MCP Hahnemann University to VN Rao; U.S. Army Medical Research grant DAMD17-94-J-4280 to VN Rao; NIH grants RO1CA85343 and RO1CA58642 to ESP Reddy and U.S. Army Medical Research Grant DAMD17-99-1-9060 to ESP Reddy.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chai, Y., Chipitsyna, G., Cui, J. et al. c-Fos oncogene regulator Elk-1 interacts with BRCA1 splice variants BRCA1a/1b and enhances BRCA1a/1b-mediated growth suppression in breast cancer cells. Oncogene 20, 1357–1367 (2001). https://doi.org/10.1038/sj.onc.1204256
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204256
Keywords
This article is cited by
-
Lipid Raft Facilitated Receptor Organization and Signaling: A Functional Rheostat in Embryonic Development, Stem Cell Biology and Cancer
Stem Cell Reviews and Reports (2023)
-
Cyclin-dependent kinase 2 (CDK2) is a key mediator for EGF-induced cell transformation mediated through the ELK4/c-Fos signaling pathway
Oncogene (2016)
-
Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma
Tumor Biology (2016)
-
Integrin αvβ6 and transcriptional factor Ets-1 act as prognostic indicators in colorectal cancer
Cell & Bioscience (2014)
-
Controversial BRCA1 allelotypes in commonly used breast cancer cell lines
Breast Cancer Research and Treatment (2010)